The Travelers Companies (TRV) is scheduled to report Q3 earnings on October 16, with analysts forecasting EPS of $6.30 on $11.15 billion in revenue, representing year-over-year growth from $5.24 and $10.7 billion, respectively, following a strong Q2 performance. Shares recently closed down 2.3% at $269.45 amidst varied analyst adjustments; while several firms like JP Morgan ($297, Underweight), UBS ($287, Neutral), Wells Fargo ($291, Equal-Weight), and Keefe, Bruyette & Woods ($316, Outperform) recently raised price targets, Barclays downgraded TRV to Equal-Weight with a reduced target of $274.
The Travelers Companies (TRV) is scheduled to report its third-quarter earnings, with analyst consensus pointing to robust year-over-year growth. Forecasts indicate EPS of $6.30, a notable increase from $5.24 in the prior-year period, alongside projected revenue of $11.15 billion, up from $10.7 billion. This follows a strong second-quarter performance that exceeded expectations, suggesting positive operational momentum. Despite these optimistic earnings projections, TRV shares experienced a 2.3% decline, closing at $269.45 on Wednesday. Analyst sentiment is notably mixed; while JP Morgan, UBS, Wells Fargo, and Keefe, Bruyette & Woods recently raised their price targets, ranging from $287 to $316, Barclays downgraded the stock to Equal-Weight and reduced its price target to $274. This divergence highlights varied expert opinions on TRV's valuation and future performance ahead of the earnings call.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment